PMID: 17015488

Sarkadi B, Homolya L, Szakacs G, Varadi A
Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system.
Physiol Rev. 2006 Oct;86(4):1179-236., [PubMed]
Sentences
No. Mutations Sentence Comment
466 ABCC4 p.Ser1173Ala
X
ABCC4 p.Ser1173Ala 17015488:466:140
status: NEW
view ABCC4 p.Ser1173Ala details
ABCB3 p.Glu552Ala
X
ABCB3 p.Glu552Ala 17015488:466:134
status: NEW
view ABCB3 p.Glu552Ala details
Interestingly, MDR1/Pgp variants containing combined mutations at the "catalytic carboxylate" and the contralateral signature region (E552A/S1173A) show vanadate-independent retention of ATP, suggesting that a closed formation of the dimer interface (with an occluded ATP) can indeed occur without ATP hydrolysis (374). Login to comment
495 ABCB1 p.Gly185Val
X
ABCB1 p.Gly185Val 17015488:495:112
status: NEW
view ABCB1 p.Gly185Val details
A spontaneous glycine to valine mutation in the intracellular end of the third transmembrane helix of MDR1/Pgp (G185V) was shown to confer increased colchicine resistance to cells. Login to comment
801 ABCG2 p.Arg482Thr
X
ABCG2 p.Arg482Thr 17015488:801:110
status: VERIFIED
view ABCG2 p.Arg482Thr details
ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 17015488:801:100
status: VERIFIED
view ABCG2 p.Arg482Gly details
Mutant variants of ABCG2 The cloning variants first characterized in drug-selected mammalian cells (R482G and R482T) caused a lot of uncertainty regarding the substrate profile of ABCG2, but became also educative regarding the substrate handling of this protein. Login to comment
802 ABCG2 p.Arg482Thr
X
ABCG2 p.Arg482Thr 17015488:802:42
status: VERIFIED
view ABCG2 p.Arg482Thr details
ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 17015488:802:33
status: VERIFIED
view ABCG2 p.Arg482Gly details
ABCG2 variants containing either R482G or R482T conferred increased mitoxantrone resistance to transfected cells; moreover, they introduced anthracyclin (doxorubicin) resistance and rhodamine-123 extrusion capacity, which were not found in the case of the wild-type protein (see Fig. 10, Refs. 127, 261). Login to comment
803 ABCG2 p.Arg482Thr
X
ABCG2 p.Arg482Thr 17015488:803:27
status: VERIFIED
view ABCG2 p.Arg482Thr details
ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 17015488:803:17
status: VERIFIED
view ABCG2 p.Arg482Gly details
In contrast, the R482G and R482T mutants were not able to extrude methotrexate, which is a transported substrate of the wild-type ABCG2 (56, 242, 393). Login to comment
804 ABCG2 p.Arg482Ser
X
ABCG2 p.Arg482Ser 17015488:804:161
status: VERIFIED
view ABCG2 p.Arg482Ser details
ABCG2 p.Arg482Met
X
ABCG2 p.Arg482Met 17015488:804:152
status: VERIFIED
view ABCG2 p.Arg482Met details
Interestingly, the same phenomenon was observed in the case of the mouse Abcg2 protein; drug selection induced a mutation exactly at the same position (R482M or R482S in the mouse Abcg2), similarly altering the substrate handling of this ortholog (5). Login to comment
810 ABCG2 p.Arg482Lys
X
ABCG2 p.Arg482Lys 17015488:810:62
status: VERIFIED
view ABCG2 p.Arg482Lys details
Mitoxantrone was transported by all ABCG2 variants, except by R482K. Login to comment
811 ABCG2 p.Arg482Lys
X
ABCG2 p.Arg482Lys 17015488:811:61
status: VERIFIED
view ABCG2 p.Arg482Lys details
ABCG2 p.Arg482Tyr
X
ABCG2 p.Arg482Tyr 17015488:811:68
status: VERIFIED
view ABCG2 p.Arg482Tyr details
Rhodamine-123 was extruded by most of the mutants, except by R482K, R482Y, and the wild-type ABCG2. Login to comment
812 ABCG2 p.Arg482Lys
X
ABCG2 p.Arg482Lys 17015488:812:19
status: VERIFIED
view ABCG2 p.Arg482Lys details
Interestingly, the R482K variant had relatively low activity in all assays, although this mutation (Arg to Lys) represents only a minor change without charge alteration. Login to comment
819 ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 17015488:819:59
status: VERIFIED
view ABCG2 p.Arg482Gly details
Transported substrates and inhibitors of the wild-type and R482G ABCG2 protein. Login to comment
820 ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 17015488:820:115
status: VERIFIED
view ABCG2 p.Arg482Gly details
The Venn diagram depicts some of the transported substrates and inhibitors (in a square) for the wild-type and the R482G mutant variant of ABCG2. Login to comment
824 ABCG2 p.Thr153Met
X
ABCG2 p.Thr153Met 17015488:824:106
status: VERIFIED
view ABCG2 p.Thr153Met details
ABCG2 p.Ala149Pro
X
ABCG2 p.Ala149Pro 17015488:824:99
status: VERIFIED
view ABCG2 p.Ala149Pro details
ABCG2 p.Pro269Ser
X
ABCG2 p.Pro269Ser 17015488:824:124
status: VERIFIED
view ABCG2 p.Pro269Ser details
ABCG2 p.Arg163Lys
X
ABCG2 p.Arg163Lys 17015488:824:113
status: VERIFIED
view ABCG2 p.Arg163Lys details
It is worth noting that in addition to the amino acid 482 ABCG2 mutations, several other variants, A149P, T153M, R163K, and P269S, were identified in different cell lines that were also not detected in healthy individuals (188, 247) (Fig. 11). Login to comment
827 ABCG2 p.Ala24Val
X
ABCG2 p.Ala24Val 17015488:827:131
status: VERIFIED
view ABCG2 p.Ala24Val details
ABCG2 p.Gln166Glu
X
ABCG2 p.Gln166Glu 17015488:827:137
status: VERIFIED
view ABCG2 p.Gln166Glu details
ABCG2 p.Phe208Ser
X
ABCG2 p.Phe208Ser 17015488:827:148
status: VERIFIED
view ABCG2 p.Phe208Ser details
In the first cloning of the ABCG2 cDNA from human placenta (8), several sequence alterations causing amino acid changes, including A24V, Q166E, and F208S, were recorded, compared with the database reference sequence. Login to comment
997 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 17015488:997:74
status: VERIFIED
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 17015488:997:68
status: VERIFIED
view ABCG2 p.Val12Met details
ABCG2 p.Ile206Leu
X
ABCG2 p.Ile206Leu 17015488:997:81
status: VERIFIED
view ABCG2 p.Ile206Leu details
ABCG2 p.Asn590Tyr
X
ABCG2 p.Asn590Tyr 17015488:997:109
status: VERIFIED
view ABCG2 p.Asn590Tyr details
ABCG2 p.Asp620Asn
X
ABCG2 p.Asp620Asn 17015488:997:116
status: VERIFIED
view ABCG2 p.Asp620Asn details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 17015488:997:95
status: VERIFIED
view ABCG2 p.Ser441Asn details
ABCG2 p.Phe489Leu
X
ABCG2 p.Phe489Leu 17015488:997:102
status: VERIFIED
view ABCG2 p.Phe489Leu details
ABCG2 p.Phe431Leu
X
ABCG2 p.Phe431Leu 17015488:997:88
status: VERIFIED
view ABCG2 p.Phe431Leu details
In healthy individuals or patients, altogether eight nonsynonymous (V12M, Q141K, I206L, F431L, S441N, F489L, N590Y, D620N), five synonymous (silent) (c. Login to comment
1002 ABCG2 p.Gln126*
X
ABCG2 p.Gln126* 17015488:1002:40
status: VERIFIED
view ABCG2 p.Gln126* details
1425AϾG) mutations, one nonsense (Q126X, c. Login to comment
1005 ABCG2 p.Gln126*
X
ABCG2 p.Gln126* 17015488:1005:21
status: VERIFIED
view ABCG2 p.Gln126* details
The sequence variant Q126X, leading to premature termination of protein synthesis, was consistently observed in certain Japanese cohorts, while absent in different Caucasian and African American groups (145, 148, 185). Login to comment
1006 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 17015488:1006:74
status: VERIFIED
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 17015488:1006:64
status: VERIFIED
view ABCG2 p.Val12Met details
From these numerous reported alterations, two protein variants, V12M, and Q141K, were found in relatively high frequencies, with significant differences in allele frequencies in different areas of the world (Fig. 11). Login to comment
1007 ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 17015488:1007:4
status: VERIFIED
view ABCG2 p.Val12Met details
The V12M polymorphism affects the NH2-terminal intracellular region of the protein. Login to comment
1009 ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 17015488:1009:4
status: VERIFIED
view ABCG2 p.Val12Met details
The V12M polymorphism was found in all ethnic groups tested, with the highest allele frequency in Mexican-Indians (90%), while only 2% in a Swedish population (18, 418), and also with a significant difference in allele frequencies in Caucasian and Japanese populations. Login to comment
1010 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 17015488:1010:4
status: VERIFIED
view ABCG2 p.Gln141Lys details
The Q141K polymorphism leads to the replacement of the uncharged glutamine residue with a positively charged lysine within the ATP-binding domain, between the Walker A motif (amino acids 83-89) and the signature region (amino acids 186-189). Login to comment
1011 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 17015488:1011:4
status: VERIFIED
view ABCG2 p.Gln141Lys details
The Q141K variant was also detected in all ethnic groups tested: the allele frequency ranged between 1 and 35% (the African and African-American subjects with low, while the Japanese and Chinese populations with high allele frequencies; see Refs. 45, 74, 185). Login to comment
1016 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 17015488:1016:104
status: VERIFIED
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 17015488:1016:186
status: VERIFIED
view ABCG2 p.Val12Met details
(251), by using stable mammalian expression systems, found that in PA317 or HEK-293 cells the expressed Q141K ABCG2 protein had a lower expression level than the wild-type ABCG2, or the V12M variant. Login to comment
1018 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 17015488:1018:42
status: VERIFIED
view ABCG2 p.Gln141Lys details
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 17015488:1018:139
status: VERIFIED
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 17015488:1018:33
status: VERIFIED
view ABCG2 p.Val12Met details
(251) demonstrated that both the V12M and Q141K ABCG2 could reach the plasma membrane in the HEK-293 cells, while a significant portion of Q141K remained intracellular. Login to comment
1019 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 17015488:1019:73
status: VERIFIED
view ABCG2 p.Gln141Lys details
Other studies found a 30-40% reduction in cell surface expression of the Q141K variant, despite a similar mRNA level than the wild-type ABCG2 (145, 188). Login to comment
1020 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 17015488:1020:98
status: VERIFIED
view ABCG2 p.Gln141Lys details
Recent investigation of 99 Japanese placenta samples revealed that individuals homozygous for the Q141K variant showed significantly lower expression levels of this transporter protein, while the heterozygous samples displayed an intermediate expression level (185). Login to comment
1023 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 17015488:1023:134
status: VERIFIED
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 17015488:1023:181
status: VERIFIED
view ABCG2 p.Val12Met details
(247) expressed ABCG2 in polarized LLC-PK1 cells, and by using confocal microscopy, the authors observed that the wild-type ABCG2 and Q141K showed mainly apical staining, while the V12M variant 1210 SARKADI, HOMOLYA, SZAKA´ CS, AND VA´ RADI Physiol Rev • VOL 86 • OCTOBER 2006 • www.prv.org showed mostly intracellular localization. Login to comment
1025 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 17015488:1025:54
status: VERIFIED
view ABCG2 p.Gln141Lys details
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 17015488:1025:122
status: VERIFIED
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 17015488:1025:45
status: VERIFIED
view ABCG2 p.Val12Met details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 17015488:1025:113
status: VERIFIED
view ABCG2 p.Val12Met details
(188) also used LLC-PK1 cells to express the V12M and Q141K variants and found that all polymorphisms, including V12M and Q141K, had an apical localization. Login to comment
1028 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 17015488:1028:24
status: VERIFIED
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 17015488:1028:16
status: VERIFIED
view ABCG2 p.Val12Met details
(247), when the V12M or Q141K-transfected LLC-PK1 cells were challenged by mitoxantrone, topotecan, or an indolocarbazole topoisomerase I inhibitor. Login to comment
1030 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 17015488:1030:26
status: VERIFIED
view ABCG2 p.Gln141Lys details
(251) found that only the Q141K variant had a moderately lower level resistance against mitoxantrone, topotecan, or SN-38, compared with the wild-type ABCG2-transfected cells. Login to comment
1032 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 17015488:1032:0
status: VERIFIED
view ABCG2 p.Gln141Lys details
Q141K is mapped to a functionally important ABC region of ABCG2; therefore, it is possible that the ATPase activity of this variant is altered. Login to comment
1033 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 17015488:1033:78
status: VERIFIED
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 17015488:1033:69
status: VERIFIED
view ABCG2 p.Val12Met details
Two studies compared the vanadate-sensitive ATPase activity of ABCG2 V12M and Q141K variants, using Sf9 (Spodoptera frugiperda) cell membranes (247, 251). Login to comment
1034 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 17015488:1034:68
status: VERIFIED
view ABCG2 p.Gln141Lys details
A reduced basal ATPase activity was observed by both groups for the Q141K variant. Login to comment
1035 ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 17015488:1035:23
status: VERIFIED
view ABCG2 p.Val12Met details
On the other hand, the V12M ABCG2 showed a similar ATPase activity as the wild-type protein. Login to comment
1038 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 17015488:1038:105
status: VERIFIED
view ABCG2 p.Gln141Lys details
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 17015488:1038:173
status: VERIFIED
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 17015488:1038:164
status: VERIFIED
view ABCG2 p.Val12Met details
Clearly, more detailed studies are required to clarify the mechanism of a reduced protein expression for Q141K, and the altered cellular localization found for the V12M and Q141K variants under certain conditions. Login to comment
1047 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 17015488:1047:117
status: VERIFIED
view ABCG2 p.Gln141Lys details
A recent investigation performed an exploratory, retrospective evaluation of the functional consequence of the ABCG2 Q141K variant in 20 adult patients, treated with diflomotecan, a synthetic derivative of camptothecin (350). Login to comment
1050 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 17015488:1050:105
status: VERIFIED
view ABCG2 p.Gln141Lys details
This observation is in harmony with studies indicating a reduced protein expression and function for the Q141K variant, while it seems to contradict the results of De Jong et al. Login to comment
1052 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 17015488:1052:44
status: VERIFIED
view ABCG2 p.Gln141Lys details
As mentioned above, the allele frequency of Q141K varies in diverse populations, and in Japan and China, this polymorphism appears to be common, with an overall allele frequency of ϳ30%. Login to comment
1084 ABCG2 p.Lys86Met
X
ABCG2 p.Lys86Met 17015488:1084:33
status: VERIFIED
view ABCG2 p.Lys86Met details
Clearly, a nonfunctional mutant (K86M) ABCG2 variant induces a dominant negative effect, that is, a nonfunctional dimer formation suppresses the activity of the wild-type protein (93, 166). Login to comment
1113 ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 17015488:1113:41
status: VERIFIED
view ABCG2 p.Arg482Gly details
Because the substrate specificity of the R482G variant of ABCG2 differs from that of the wild-type protein, this mutant has a special advantage in gene therapy applications. Login to comment